Clarivate Plc (NYSE:CLVT) Receives $7.78 Consensus PT from Analysts

Shares of Clarivate Plc (NYSE:CLVTGet Free Report) have received a consensus recommendation of “Hold” from the nine research firms that are currently covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $7.78.

A number of brokerages recently weighed in on CLVT. Barclays lowered their price objective on shares of Clarivate from $7.00 to $6.00 and set an “underweight” rating for the company in a research report on Wednesday, February 28th. The Goldman Sachs Group dropped their price target on Clarivate from $8.50 to $7.50 and set a “buy” rating on the stock in a research report on Thursday, May 9th. Oppenheimer lowered their price objective on Clarivate from $11.00 to $10.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Royal Bank of Canada dropped their target price on Clarivate from $10.00 to $8.00 and set a “sector perform” rating on the stock in a research report on Wednesday, February 28th. Finally, Morgan Stanley reduced their target price on shares of Clarivate from $9.00 to $8.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 28th.

Read Our Latest Stock Report on CLVT

Clarivate Price Performance

Shares of CLVT opened at $5.34 on Friday. Clarivate has a 52 week low of $5.32 and a 52 week high of $10.03. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 1.03. The firm has a market cap of $3.57 billion, a price-to-earnings ratio of -3.22, a PEG ratio of 3.84 and a beta of 1.20. The stock has a 50 day moving average of $6.44 and a 200-day moving average of $7.69.

Clarivate (NYSE:CLVTGet Free Report) last released its quarterly earnings data on Wednesday, May 8th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.02. The firm had revenue of $621.20 million during the quarter, compared to the consensus estimate of $614.57 million. Clarivate had a negative net margin of 39.29% and a positive return on equity of 10.11%. As a group, analysts forecast that Clarivate will post 0.62 EPS for the current year.

Institutional Investors Weigh In On Clarivate

Several hedge funds and other institutional investors have recently bought and sold shares of CLVT. Evermay Wealth Management LLC bought a new position in shares of Clarivate during the 1st quarter valued at about $31,000. Banque Cantonale Vaudoise acquired a new position in Clarivate in the third quarter worth approximately $33,000. Montag A & Associates Inc. grew its position in Clarivate by 729.6% in the fourth quarter. Montag A & Associates Inc. now owns 7,732 shares of the company’s stock worth $72,000 after buying an additional 6,800 shares during the last quarter. J.W. Cole Advisors Inc. bought a new position in shares of Clarivate in the first quarter valued at $76,000. Finally, Wedmont Private Capital acquired a new stake in shares of Clarivate during the 4th quarter valued at $99,000. 85.72% of the stock is currently owned by institutional investors.

About Clarivate

(Get Free Report

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

Featured Articles

Analyst Recommendations for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.